GVHD: Clinical Trials

1 trial for GVHD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow GVHD: new trials by email Literature Review of GVHD trials Research Report on GVHD

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I Trial of Brentuximab Vedotin for Refractory Chronic Graft-vs.-Host Disease (GVHD)
Brentuximab Vedotin - Graft-vs-Host Disease, GVHD
Phase 1TerminatedMassachusetts General Hospital192013-10-012018-07-26

Narrower conditions

Graft vs Host Disease (1)

Broader conditions

Immune System Diseases (1)

Interventions

Brentuximab Vedotin (1)

Sponsors

Massachusetts General Hospital (1)

Countries

United States (1)

Top investigators

Yi-Bin Chen, MD (1)

Results publications

PMID 28473406